TX SB883 | 2025-2026 | 89th Legislature
Status
Sponsorship: Partisan Bill (Republican 4)
Status: Engrossed on April 10 2025 - 50% progression, died in committee
Action: 2025-04-22 - Referred to Public Health
Pending: House Public Health Committee
Text: Latest bill text (Engrossed) [HTML]
Status: Engrossed on April 10 2025 - 50% progression, died in committee
Action: 2025-04-22 - Referred to Public Health
Pending: House Public Health Committee
Text: Latest bill text (Engrossed) [HTML]
Summary
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Title
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Sponsors
Roll Calls
2025-04-10 - Senate - Read 3rd time (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
2025-04-10 - Senate - Rules suspended-Regular order of business (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Read 2nd time & passed to engrossment (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Rules suspended-Regular order of business (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Passed (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Rules suspended-Regular order of business (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Rules suspended-Regular order of business (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Read 2nd time & passed to engrossment (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Rules suspended-Regular order of business (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Passed (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
2025-04-10 - Senate - Rules suspended-Regular order of business (Y: 23 N: 7 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2025-04-22 | House | Referred to Public Health |
| 2025-04-22 | House | Read first time |
| 2025-04-14 | House | Received from the Senate |
| 2025-04-10 | Senate | Reported engrossed |
| 2025-04-10 | Senate | Record vote |
| 2025-04-10 | Senate | Passed |
| 2025-04-10 | Senate | Read 3rd time |
| 2025-04-10 | Senate | Record vote |
| 2025-04-10 | Senate | Rules suspended-Regular order of business |
| 2025-04-10 | Senate | Record vote |
| 2025-04-10 | Senate | Read 2nd time & passed to engrossment |
| 2025-04-10 | Senate | Record vote |
| 2025-04-10 | Senate | Rules suspended-Regular order of business |
| 2025-04-10 | Senate | Co-author authorized |
| 2025-04-09 | Senate | Placed on intent calendar |
| 2025-04-07 | Senate | Committee report printed and distributed |
| 2025-04-07 | Senate | Reported favorably w/o amendments |
| 2025-04-02 | Senate | Vote taken in committee |
| 2025-04-02 | Senate | Considered in public hearing |
| 2025-04-01 | Senate | Left pending in committee |
| 2025-04-01 | Senate | Testimony taken in committee |
| 2025-04-01 | Senate | Considered in public hearing |
| 2025-04-01 | Senate | Scheduled for public hearing on . . . |
| 2025-03-20 | Senate | Co-author authorized |
| 2025-02-13 | Senate | Referred to Health & Human Services |
| 2025-02-13 | Senate | Read first time |
| 2025-01-23 | Senate | Filed |
| 2025-01-23 | Senate | Received by the Secretary of the Senate |
Subjects
COVID-19
Health
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
MEDICAL BOARD, TEXAS
MEDICINE & PRESCRIPTION DRUGS
PHYSICIANS
RIGHT TO TREAT ACT
Health
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
MEDICAL BOARD, TEXAS
MEDICINE & PRESCRIPTION DRUGS
PHYSICIANS
RIGHT TO TREAT ACT
